Angeliq oral once-daily estradiol and drospirenone regulatory update

The Netherlands granted marketing approval to SCH for its Angeliq hormone replacement therapy (HRT) to treat menopausal symptoms and to prevent osteoporosis in women. In October, the FDA issued a non-...